This site is intended for Healthcare Professionals only
2026-09-23 13:00:26 (8 day(s) ago)
B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg powder and solvent for solution for infusion.